StockData
GeneDx Holdings Corp. logo

GeneDx Holdings Corp. (WGS) stock

WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.02−1.35 (-2.58%)

Close on Nov 16, 2026Market cap $1.52BP/E –Yield –

GeneDx enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

GeneDx's enterprise value was $1.60B on Nov 10, 2026, against $4.72B a year earlier. Over the last 5 years it ranged from -$139.68M to $4.72B, with a median of $622.03M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 10, 2026$1.60B-56.3%
2025Dec 31, 2025$3.65B+78.7%
2024Dec 31, 2024$2.04B–
2023Dec 29, 2023-$36.89M–
2022Dec 30, 2022-$95.56M–
2021Jan 29, 2021-$139.68M–
2020Dec 31, 2020-$139.68M–

More GeneDx figures

See a number that looks wrong?